AACR 2014 - Pharmaco-imaging study of the effects of Debio1143, a new orally available IAP inhibitor, in a triple-negative breast cancer model

Centre Georges-François Leclerc, Oncodesign, Debiopharm International SA, ICMUB

DOWNLOAD

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.